Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

39.97
Delayed Data
As of May 24
 +0.55 / +1.40%
Today’s Change
26.02
Today|||52-Week Range
52.33
-10.94%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close39.42
Today’s open39.78
Day’s range39.39 - 40.01
Volume751,832
Average volume (3 months)1,280,576
Market cap$5.5B
Dividend yield--
Data as of 05/24/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-18.41%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book8.03

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc+0.39+3.88%
TAROTaro Pharmaceutical ...+2.89+2.15%
UTHRUnited Therapeutics ...+2.44+2.14%
MNKMallinckrodt Plc+1.64+2.77%
Data as of 05/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

Partner Offers

Search for Jobs